Pentagon rescinds new testosterone screening policy without explanation
The Pentagon says the guidance is being updated after being online for one day.
The Pentagon says the guidance is being updated after being online for one day.
The short version
- The next day, though, the clinical guidance document disappeared, as did an accompanying statement by spokesperson Sean Parnell.
- The withdrawal was first reported by Reuters .
- In a statement sent to Ars Technica, the Pentagon said that the document, titled “Clinical Guidance for Health and Human Performance Optimization,” had been temporarily rescinded on September 3 to allow for updates.
What happened
“The Department remains committed to addressing hormone deficiencies, protecting the long-term health of its Service members, and enabling peak operational performance,” the Pentagon said. An interim guidance remains in effect, and “the final clinical guidance will be issued shortly,” it added.
Why it matters
The Pentagon declined to provide more information regarding what was being updated about the guidance and why it needed to be updated so quickly after its release.
Summary by Nerd News Network. Read the full article at Ars Technica via the links above and below.